Dr. Lal PathLabs Limited (BOM:539524)
India · Delayed Price · Currency is INR 1,920.75
+18.45 (0.97%)
At close: Oct 28, 2026
Dr. Lal PathLabs Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 321,546 | 219,260 | 206,551 | 187,931 | 151,339 | 215,706 | |
Market Cap Growth | 22.40% | 6.15% | 9.91% | 24.18% | -29.84% | -3.39% |
Enterprise Value | 310,560 | 208,146 | 197,605 | 182,294 | 149,438 | 206,326 |
Last Close Price | 1920.75 | 1307.25 | 1222.07 | 1106.88 | 885.32 | 1255.85 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 59.28 | 43.44 | 42.40 | 52.53 | 63.36 | 62.55 |
PS Ratio | 11.12 | 7.94 | 8.39 | 8.44 | 7.50 | 10.33 |
PB Ratio | 12.65 | 8.63 | 9.36 | 9.97 | 8.90 | 14.03 |
P/TBV Ratio | 18.19 | 12.41 | 15.04 | 18.85 | 19.91 | 39.39 |
P/FCF Ratio | 68.62 | 46.79 | 39.37 | 38.82 | 36.08 | 61.18 |
P/OCF Ratio | 50.59 | 34.50 | 36.31 | 35.10 | 33.19 | 48.29 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 10.74 | 7.53 | 8.03 | 8.19 | 7.41 | 9.88 |
EV/EBITDA Ratio | 37.42 | 28.11 | 30.03 | 32.14 | 33.87 | 39.77 |
EV/EBIT Ratio | 46.27 | 33.26 | 35.33 | 38.94 | 43.93 | 45.38 |
EV/FCF Ratio | 66.28 | 44.42 | 37.67 | 37.65 | 35.62 | 58.52 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.08 | 0.08 | 0.07 | 0.13 | 0.25 | 0.35 |
Debt / EBITDA Ratio | 0.24 | 0.25 | 0.23 | 0.41 | 0.87 | 0.96 |
Debt / FCF Ratio | - | 0.43 | 0.30 | 0.51 | 1.00 | 1.51 |
Net Debt / Equity Ratio | -0.44 | -0.44 | -0.46 | -0.37 | -0.23 | -0.10 |
Net Debt / EBITDA Ratio | -1.43 | -1.53 | -1.53 | -1.23 | -0.89 | -0.29 |
Net Debt / FCF Ratio | - | -2.41 | -1.92 | -1.44 | -0.94 | -0.42 |
Asset Turnover | - | 0.94 | 0.95 | 0.92 | 0.85 | 1.04 |
Inventory Turnover | - | 27.99 | 27.53 | 26.65 | 20.66 | 19.34 |
Quick Ratio | - | 3.28 | 3.20 | 2.27 | 1.93 | 1.57 |
Current Ratio | - | 3.48 | 3.39 | 2.43 | 2.07 | 1.75 |
Return on Equity (ROE) | - | 21.47% | 24.06% | 20.21% | 14.90% | 24.90% |
Return on Assets (ROA) | - | 13.34% | 13.51% | 12.09% | 8.98% | 14.18% |
Return on Invested Capital (ROIC) | 36.29% | 36.54% | 36.88% | 26.90% | 17.71% | 36.64% |
Return on Capital Employed (ROCE) | - | 23.20% | 24.20% | 23.50% | 17.80% | 24.60% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 1.69% | 2.30% | 2.36% | 1.90% | 1.58% | 1.60% |
FCF Yield | 1.46% | 2.14% | 2.54% | 2.58% | 2.77% | 1.64% |
Dividend Yield | 0.83% | 1.07% | 1.94% | 1.06% | 0.66% | 0.46% |
Payout Ratio | 49.38% | 42.99% | 41.03% | 55.76% | 41.62% | 33.83% |
Buyback Yield / Dilution | -0.20% | -0.19% | -0.22% | -0.14% | -0.21% | -0.24% |
Total Shareholder Return | 0.63% | 0.88% | 1.72% | 0.92% | 0.45% | 0.22% |